DESIGN THERAPEUTICS INC shareholders Q1 2023

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 100 filers reported holding DESIGN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

DESIGN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Citadel Advisors 2,865,167$16,532,0140.00%
Quantbot Technologies LP 10,853$62,6220.00%
JANUS HENDERSON GROUP PLC 843,718$4,868,2530.00%
Assenagon Asset Management S.A. 168,215$970,6010.00%
PRINCIPAL FINANCIAL GROUP INC 719,937$4,154,0360.00%
Centiva Capital, LP 23,572$136,0100.00%
TWO SIGMA INVESTMENTS, LP 179,096$1,033,3840.00%
Squarepoint Ops LLC 109,214$630,1650.00%
MILLENNIUM MANAGEMENT LLC 790,213$4,5600.00%
TUDOR INVESTMENT CORP ET AL 27,639$1590.00%
Point72 Middle East FZE 9,364$54,0300.00%
MARSHALL WACE, LLP 180,919$1,043,9020.00%
China Universal Asset Management Co., Ltd. 758$40.00%
MetLife Investment Management, LLC 22,045$127,1990.00%
BlackRock Inc. 3,185,891$18,382,5920.00%
Ameritas Investment Partners, Inc. 2,570$14,8290.00%
Renaissance Technologies 101,751$5870.00%
WELLINGTON MANAGEMENT GROUP LLP 550,332$3,175,4160.00%
SG Americas Securities, LLC 15,040$870.00%
METROPOLITAN LIFE INSURANCE CO/NY 2,016$11,6320.00%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q1 2023. To view DESIGN THERAPEUTICS INC's shareholder history, click here.